{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:10:09Z","timestamp":1789510209592,"version":"build-2803163510"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While antiretroviral therapy (ART) has significantly improved the long-term survival of people living with HIV\/AIDS, leading to a chronic disease management model, survival outcomes can be influenced by demographic and clinical factors. There is a need to evaluate the long-term survival of HIV-infected individuals initiating ART and identify local influencing factors to optimize patient management and improve prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted on HIV-infected individuals who initiated ART in Zhengzhou between 2014 and 2024. Demographic data and ART-related information were collected from the National AIDS Clinical Data System. The life table method was employed to describe patient survival time, while the Kaplan-Meier method was used to compare survival time differences under various conditions and to plot survival curves. A Cox proportional hazards regression model was applied to analyze risk factors influencing patient survival time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 3,312 HIV-infected individuals, the total follow-up time amounted to 15,656.5 person-years, with a median follow-up of 4.73 years. A total of 107 deaths were recorded, yielding a mortality rate of 0.68 per 100 person-years. The cumulative survival rates at 1, 3, 5, and 10 years were 99%, 98%, 96%, and 93%, respectively. Multivariate Cox regression analysis identified age greater than 60 years (HR = 5.570, 95% CI: 1.608\u201319.292) as a risk factor for mortality. Additionally, patients with a baseline CD4\n                      <jats:sup>+<\/jats:sup>\n                      T lymphocyte count of less than 50 cells\/\u03bcL faced a significantly higher risk of death compared to those with a count greater than 350 cells\/\u03bcL (HR = 3.777, 95% CI: 1.583\u20139.014).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      From 2014 to 2024, the overall survival of HIV-infected individuals receiving antiviral therapy in Zhengzhou was favorable. However, advanced age and a low baseline CD4\n                      <jats:sup>+<\/jats:sup>\n                      T lymphocyte count were identified as significant factors for an elevated mortality risk. It is recommended to enhance clinical management for older patients and to initiate treatment early to improve CD4\n                      <jats:sup>+<\/jats:sup>\n                      T lymphocyte levels, thereby further improving survival outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1733724","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:53:25Z","timestamp":1773212005000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival outcomes and influencing factors in Zhengzhou HIV\/AIDS patients following antiretroviral therapy initiation (2014-2024): a retrospective cohort analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Meng","family":"Deng","sequence":"first","affiliation":[{"name":"Clinical Medical Research Center, Henan Infectious Diseases Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases and Clinical Immunology, Henan Infectious Diseases Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Henan Infectious Diseases Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Center, Henan Infectious Diseases Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Center, Henan Infectious Diseases Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Center, Henan Infectious Diseases Hospital","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1068664","DOI":"10.3389\/fpubh.2023.1068664","article-title":"Global, regional, and national HIV\/AIDS disease burden levels and trends in 1990-2019: a systematic analysis for the global burden of disease 2019 study","volume":"11","author":"Tian","year":"2023","journal-title":"Front Public Health."},{"key":"B2","unstructured":"The Path That Ends Aids: Unaids Global Aids Update 2023.\n          \n          2023"},{"key":"B3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12879-025-11087-y","article-title":"Challenges of integrating HIV prevention and treatment in China's border mountain regions: a grounded theory study","volume":"25","author":"Du","year":"2025","journal-title":"BMC Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1473-3099(11)70097-4","article-title":"Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in china: a national observational cohort study","volume":"11","author":"Zhang","year":"2011","journal-title":"Lancet Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2787731","DOI":"10.1155\/2022\/2787731","article-title":"Factors influencing survival status of HIV\/AIDS after Haart in Huzhou City, Eastern China","volume":"2022","author":"Jin","year":"2022","journal-title":"Can J Infect Dis Med Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1186\/s12889-023-15662-3","article-title":"Survival times of HIV\/AIDS in different aids diagnostic and treatment guidelines from 2006 to 2020 in Liuzhou, China","volume":"23","author":"Ke","year":"2023","journal-title":"BMC Public Health."},{"key":"B7","doi-asserted-by":"publisher","first-page":"28005","DOI":"10.1038\/srep28005","article-title":"Mortality among people living with HIV and AIDS in China: implications for enhancing linkage","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3760\/cma.j.cn112150-20200506-00691","article-title":"Survival time and related factors of antiretroviral therapy among HIV\/AIDS patients in Liangshan prefecture, during 2005-2015","volume":"54","author":"Jiang","year":"2020","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi."},{"key":"B9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3760\/cma.j.issn.0254-6450.2019.08.012","article-title":"Survival analysis on HIV\/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin","volume":"40","author":"Guo","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"B10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3760\/cma.j.issn.0254-6450.2019.01.015","article-title":"Survival status and influencing factors of HIV\/AIDS on highly active anti-retrovial therapy in Shandong Province","volume":"40","author":"Zhang","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3760\/cma.j.cn112338-20240429-00228","article-title":"Survival status and influencing factors of death risk of HIV-infected patients in Hangzhou, 2004-2023","volume":"45","author":"Chen","year":"2024","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S2666-7568(22)00041-1","article-title":"Ageing with HIV","volume":"3","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"102520","DOI":"10.1016\/j.jiph.2024.102520","article-title":"Survival rate and its predictors in HIV patients: a 15-year follow-up of 3030 patients","volume":"17","author":"Naghibifar","year":"2024","journal-title":"J Infect Public Health."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12979-024-00497-2","article-title":"Limited restoration of T cell subset distribution and immune function in older people living with HIV-1 receiving haart","volume":"22","author":"Li","year":"2025","journal-title":"Immun Ageing."},{"key":"B15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/1471-2458-13-397","article-title":"Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study","volume":"13","author":"Iwuji","year":"2013","journal-title":"BMC Public Health."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/cid\/ciw183","article-title":"Mortality according to CD4 count at start of combination antiretroviral therapy among HIV-infected patients followed for up to 15 years after start of treatment: collaborative cohort study","volume":"62","author":"May","year":"2016","journal-title":"Clinl Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0036-1572553","article-title":"Human immunodeficiency virus infection and host defense in the lungs","volume":"37","author":"Charles","year":"2016","journal-title":"Semin Respir Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3760\/cma.j.cn112150-20220112-00045","article-title":"Survival analysis of long-term HIV\/AIDS cases aged 15 years and over under antiretroviral treatment in Henan Province from 2002 to 2020","volume":"56","author":"Yang","year":"2022","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1614619","DOI":"10.3389\/fpubh.2025.1614619","article-title":"Survival analysis and factors influencing survival time of adult HIV\/AIDS patients receiving antiretroviral therapy from 2012 to 2022 in Chongqing, China: a retrospective cohort study","volume":"13","author":"Huang","year":"2025","journal-title":"Front Public Health."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1733724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:53:31Z","timestamp":1773212011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1733724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":19,"alternative-id":["10.3389\/fpubh.2026.1733724"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1733724","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1733724"}}